Chugai Pharmaceutical Co., Ltd. and Cheplapharm K.K. announced that Chugai will transfer the business in Japan concerning the anti-cancer agent Tarceva tablets 25, 100, and 150 to Cheplapharm. Chugai in-licensed Tarceva from Roche and is the marketing …

For any hopes the dealmaking that started the J.P. Morgan Healthcare Conference would give the overall biotechnology sector a running start to 2025, Eli Lilly deflated them Tuesday.  The company, which rose to new heights on the success of its medicines …

China Resources Pharmaceutical Group (CR Pharmaceutical) has teamed up with the Hong Kong government’s Nano and Advanced Materials Institute (NAMI) to research the repurposing of a cancer drug to treat Alzheimer’s disease. Hong Kong-listed CR …

Each year at the J.P. Morgan Healthcare Conference, pharma CEOs are tasked with assuring and convincing investors that they’ve positioned their companies to overcome expected challenges. Monday, three Big Pharma leaders took center stage and addressed …

 Annovis Bio Inc. announced it was granted the U.S. patent covering methods for the treatment and prevention of acute brain or nerve injuries using buntanetap. This newly issued patent is based on buntanetap’s ability to reduce neurotoxicity and mitigate …

… rules for what can be patented, vastly expanding patent eligibility. For … strategies like “patent thicketing,” where pharmaceutical companies, among others, shroud their …

… similar cases in which drug companies have been ostracized for their … Some 78 percent of the patented drugs marketed between 2005 … the fastest-growing pharma market, the British drugmaker GSK paid a … . are generics, copies of patent-expired drugs. As copies, …

VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …

MALVERN, Pa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’ …